Antibody medicines
搜索文档
Genmab(GMAB) - 2026 Q1 - Earnings Call Transcript
2026-05-08 01:02
Genmab (NasdaqGS:GMAB) Q1 2026 Earnings call May 07, 2026 12:00 PM ET Company ParticipantsAnthony Pagano - CFOBenjamin Jackson - VP of Equity ResearchBrad Bailey - Chief Commercial OfficerJames Gordon - Director and Head of European Pharma, Biotech, and Life Sciences Equity ResearchJan van de Winkel - President, and CEOJudith Klimovsky - Executive Vice President and Chief Development OfficerMatthew Phipps - Partner and Group Head of Biotechnology Equity ResearchMichael Schmidt - Senior Managing DirectorRaja ...